– 13F, 13D, 13G Filings – Fintel.io.
…
BlackRock Inc. reports 29.83% decrease in ownership of ZOM / Zomedica Pharmaceuticals Corp.
Security | ZOM / Zomedica Pharmaceuticals Corp. |
---|---|
Latest Disclosed Value | $ 3,896,000 |
Similarly Is Vanguard invested in Zomedica? Institutional investors has been set as your preferred Vanguard website.
…
1-50 of 4041 | Next>
Holding | Shares | Market Value |
---|---|---|
Zomedica Corp. | 17,423,257 | $6,274,115 |
Zogenix Inc. | 1,723,411 | $45,256,773 |
Zoetis Inc. | 13,570,958 | $2,628,016,017 |
How many shares does Zom have? Share Statistics
Avg Vol (3 month) 3 | 18.11M |
---|---|
Shares Outstanding 5 | 979.9M |
Implied Shares Outstanding 6 | N/A |
Float 8 | 955.44M |
% Held by Insiders 1 | 2.63% |
Additionally, Should I invest in ZOM?
ZOM stock is a risky bet in the pet diagnostics field, but it’s affordable and could provide powerful gains in the long-term. Or its downward spiral could continue; that’s a possibility which prospective investors should always consider.
Why is ZOM dropping?
CEO Robert Cohen said the move was precipitated by « changes at our current distributor that we believe have impacted its ability to market our products effectively. » Those words likely startled investors, many of whom decided to sell their shares. Zomedica’s stock price dropped sharply on Thursday.
Is ZOM shorted? Short Shares Availability
This table shows the number of shares of US:ZOM available to be shorted at a leading prime brokerage. It is not the total number of shares available to short, nor is it the short interest.
Is Castor Maritime a good buy? Castor Maritime Inc.
holds several positive signals and is within a strong rising trend. As the old saying says, « Let the trend be your friend. ‘ ». We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
Is ZOM undervalued? InvestorPlace’s Mark Hake estimates Zomedica (NYSEAMERICAN:ZOM) is worth between $1.11 and $1.61 a share. That makes ZOM stock a buy at current prices.
Is Acasti Pharma a good stock to buy?
Is ACASTI PHARMA Stock a good buy in 2022, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering (NASDAQ: ACST) stock is to Buy ACST stock.
Is Zomedica a pump and dump? Zomedica Pharmaceuticals (NYSEMKT:ZOM) stock is the latest pump-and-dump looking to take investors for a ride.
Who is shorting Zom?
Short selling ZOM is an investing strategy that aims to generate trading profit from Zomedica as its price is falling. Zomedica’s stock is trading up $0.02 today. To short Zomedica stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender.
What are the most shorted stocks? Most Shorted Stocks Right Now
- Nikola Corporation (NASDAQ:NKLA) Number of Hedge Fund Holders: 12. Float Shorted: 30.02% …
- Bed Bath & Beyond Inc. (NASDAQ:BBBY) Number of Hedge Fund Holders: 17. …
- SmileDirectClub, Inc. (NASDAQ:SDC) Number of Hedge Fund Holders: 18. …
- Beyond Meat, Inc. (NASDAQ:BYND) …
- Lemonade, Inc. (NYSE:LMND)
Is Zomedica in a short squeeze?
Zomedica Corp (ZOM) Stock Moves To One Month High On Short Squeeze.
What is the future of CTRM stock?
Castor Maritime (CTRM) stock forecast 2022-2025
The site suggested that the stock could be a few cents shy of $4.7 in 2024, almost reach $6.5 by 2025, and be closing in on $8.2 a year later. A five year forecast for the stock, meanwhile, suggested it could be touching $9.96 by 2027.
Is Castor Maritime a real company? It’s Magic, It’s Shipping, It’s Castor!
We are a growth-oriented global shipping company engaged in the seaborne transportation of a wide range of commodities along worldwide shipping routes through our ownership of dry bulk and tanker vessels.
Who owns SNDL? Common Shares (SNDL) Institutional Holdings | Nasdaq.
…
New and Sold Out Positions.
OWNER NAME | CAPROCK GROUP, INC. |
---|---|
SHARES HELD | 1,240,000 |
CHANGE (SHARES) | 310,000 |
CHANGE (%) | 33.333% |
VALUE (IN 1,000S) | $657 |
Is ZOM a meme stock?
A couple of meme stocks that stand out as incredibly risky today are Zomedica ( ZOM 1.80% ) and Digital World Acquisition Corp ( DWAC 0.73% ).
Is ZOM stock overvalued? The Zomedica Pharmaceuticals Corp stock price gained 1.96% on the last trading day (Thursday, 14th Apr 2022), rising from $0.30 to $0.31.
…
Predicted Opening Price for Zomedica Pharmaceuticals Corp of Monday, April 18, 2022.
Fair opening price April 18, 2022 | Current price |
---|---|
$0.30 | $0.31 (Overvalued) |
Is ZOM overvalued?
Zomedica Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology.
Will Acasti Pharma go up? Acasti Pharma Inc (NASDAQ:ACST)
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +327.35% increase from the last price of 1.17.
Why is Acasti Pharma dropping?
Acasti Pharma stock dropped from $2.18 to under $1 in a single trading session. Valentine’s Day turned out to be no sweeter for ACST stock. The stock fell further when the company posted a larger loss than expected. For the company’s 2020 fiscal third quarter, it posted a loss of 14 cents per share.
Is AQST a good stock to buy? The consensus among 2 Wall Street analysts covering (NASDAQ: AQST) stock is to Strong Buy AQST stock.